ArticleBioscience reports2019

LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.

Si Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.